For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Search Posts
Blog
Health care taxes — devastating effects for NYC
Lead headline on the Drudge Report today – “Terrifying 57% tax looms for biggest earners in NYC.” It links to a…
News Release
Obama Surgeon General Pick Challenged to Focus on Private Initiative, Not Government Controls
President Obama announced his pick for Surgeon General this week – Dr. Regina M. Benjamin, a family physician from Bayou La Batre, Ala. Competitive Enterprise…
Op-Eds
Obama Administration = Waste, Corruption, Corporate Welfare
Rapidly-rising Medicare spending already threatens “to crush the federal budget,” and much Medicare spending is wasteful, yet the Obama Administration claims it can somehow…
Newsletter
Chemical Safety, Global Warming Balance Sheets and Hybrid Smugness
Canadian officials find that the presence of bisphenol A, a chemical used in plastic food containers, poses “no health or safety concerns.” The Securities and…
Newsletter
Safe Bottled Water, a Second Stimulus and Keeping Government out of Insurance
Rep. Bart Stupak (D-MI) questions the safety of the U.S. bottled water industry. Officials consider putting together a second stimulus package to follow the $787…
Blog
Government health care monopoly–not in consumers’ interests
Regina Herzlinger, chair of Harvard Business School, in National Review takes on health care and the Obama Administration’s arguments that a government-run plan…